Hints and tips:
Showing results for Senders v. Pfizer Inc
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...“The big mystery of the year has been the disconnect between the chaos in Washington and the calmness in markets,” says Adam Sender, head of Sender Company and Partners, a hedge fund....
...Henny Sender in Hong Kong reports WME-IMG is teaming up with venture firm Sequoia Capital China and internet group Tencent to expand the US sports and entertainment conglomerate’s Chinese business....
...However, TPG had to overcome tough questions about the performance of TPG V, its boom-era buyout fund, which invested $15.5bn but suffered some high-profile casualties....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Dealmakers say both the capital markets records and the jump in M&A are being driven by a rise in confidence following Asia’s V-shaped recovery from the global financial crisis, which is estimated by the...
...Overall, Blackstone Capital Partners V was up $2.4bn, or nearly 20 per cent, in the first quarter, its letter said. TPG V was up 0.5 per cent, or $40m, investors were told....
...The estimated value of the investments was detailed in a report dated May 28 sent to investors in the TPG Partners V fund....
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...The letter noted that Linens “received outsized negative publicity, but placed in the context of Apollo’s portfolio investments, it is only one of 20 portfolio companies in Fund V that did not work out and...
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition